Conjugated Bile Acids and the Liver-Muscle Axis: Authors' Reply to the Perspectives on Causal and Contextual Interpretation [0.03%]
conjugated胆汁酸和肝肌轴：作者对因果关系和背景解读的回应视角
Motoh Iwasa,Akiko Eguchi
Motoh Iwasa
Conjugated Bile Acids and the Liver-Muscle Axis in Chronic Liver Disease: A Mechanism, but Caution in Causal Interpretation [0.03%]
胆酸与慢性肝病中的肝肌轴：一种机制，但在因果解释上需谨慎
Cheng Wang,Baodong Wang,Sumei Xu
Cheng Wang
HDV RNA Undetectability Rates During Bulevirtide Monotherapy in Patients With Chronic Hepatitis Delta May Be Assay Dependent [0.03%]
布立西韦单药治疗慢性丁型肝炎患者时其体内HDV RNA未检出率可能受检测方法的影响
Maria Paola Anolli,Sara Uceda Renteria,Elisabetta Degasperi et al.
Maria Paola Anolli et al.
Distinct Roles of Myeloid- and Hepatocyte-PLA2G6 Deletion in Mice With Metabolic Dysfunction-Associated Steatotic Liver Disease [0.03%]
在代谢功能障碍相关性肝脂肪变性疾病小鼠中，髓系和肝细胞源性 PLA2G6 缺失的不同作用
Gang Li,Simone Staffer,Sabine Tuma-Kellner et al.
Gang Li et al.
Background and aims: Polymorphisms of group VIA calcium-independent phospholipase A2 (iPLA2β or PLA2G6) are associated with Type-2 diabetes, blood lipids and inflammation. Global deficiency in iPLA2β-null mice elicited ...
Clinical Setting Modulates the Association Between Genetic Variants and Fibrosis Severity Across the Spectrum of MASLD [0.03%]
临床环境调节MASLD谱系纤维化严重程度的遗传变异关联性
Mei-Hsuan Lee,Maria Stepanova,Michael Estep et al.
Mei-Hsuan Lee et al.
Background and aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease worldwide. Although genetic variants are linked to MASLD progression, whether their assoc...
Faecal Cathepsin B and S Are Associated With Liver Disease Severity and Adiposity in MASLD [0.03%]
粪便猫肉蛋白B和S与MASLD肝病严重程度和肥胖的关系
Aenne Harberts,Marcos F Fondevila,Henriette Kreimeyer et al.
Aenne Harberts et al.
Background & aims: Dysregulation of hepatic cathepsins contributes to metabolic dysfunction-associated steatotic liver disease (MASLD) by promoting inflammation, apoptosis, and fibrosis. However, the role of intestinal ca...
Driving HCV Elimination Through Dedicated Hospital-Based Teams and Pathways: A Retrospective and Prospective Study [0.03%]
基于医院的团队和途径驱动的丙肝消除：回顾性和前瞻性研究
Pietro Torre,Enrica Serretiello,Giuseppe Di Siervi et al.
Pietro Torre et al.
Induction of Clinical Operational Tolerance Through Immunosuppression Minimization: Less Is More? [0.03%]
通过降低免疫抑制诱导临床操作耐受性：少即是多？
Emilia Knioła,Bartosz Foroncewicz,Jan Lerut et al.
Emilia Knioła et al.
The goal of achieving clinical operational tolerance in liver transplantation has sparked significant interest, driven by the desire to mitigate the long-term adverse effects of immunosuppression. Advances in understanding the immunological...